Answers are grounded in this paper and cite their sources.
The activity of teichomycin A2 was compared with that of vancomycin in vitro against clinical isolates of staphylococci and enterococci. Teichomycin A2 was more active than vancomycin active against all isolates tested. Synergistic studies also demonstrated that teichomycin A2 combined with rifampin is more active than vancomycin combined with rifampin against Staphylococcus aureus and Staphylococcus epidermidis isolates. Teichomycin A2, either singly or in combination with an aminoglycoside, was more active against Streptococcus faecalis isolates.
No takes yet. Share an insight, caveat, or question.
Tuazon et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: